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ABSTRACT 
Introduction: Zambia is among the countries in the sub-Saharan African region most severely 
affected with HIV/AIDS. Approximately 1.2 million (14%) Zambians were living with HIV in 
2010. Zambia introduced antiretroviral therapy (ART) in the public sector in 2002, starting with 
two pilot sites, and rolling it out throughout the country in 2004 and 2005. To date, 
approximately 350,000 people have accessed HIV treatment. The long-term success of ART 
programs depends on optimal adherence to ART by patients.   
In 2010 Livingstone General Hospital (LGH), the setting for the current research had over 7,000 
enrolled for HIV care of whom 3,880 patients were on ART. By the end of June 2011, it was 
reported that 343 patients in this hospital were between 2 to 30 days late for their medication 
refill appointments. This meant that these patients had missed more than one dose, and thus not 
meeting the required 95% of medication for viral suppression. 
This study explored the barriers to medication adherence experienced by ART patients at 
Livingstone General Hospital (LGH). 
Methodology: An exploratory qualitative study was conducted. Six focus group discussions 
(FGD) were conducted with 42 patients on ART, and follow up semi-structured interviews with 
7 patients identified during the FGDs. FGDs and semi-structured interviews were audio-tape 
recorded and transcribed verbatim. Thematic and content analysis of transcribed data was done. 
Results: The study found that the barriers to ART adherence included socio-economic factors 
such as poverty, use of traditional complementary and alternative medicines (TCAM) and 
religious beliefs. Patient related factors reported to negatively affect adherence were HIV 
related-stigma and discrimination, alcohol use, low literacy and education levels, busy daily 
schedules and forgetfulness. Regimen related factors included experiencing side effects to 
medication and complexity of treatment regimen. Negative staff attitudes, traveling long 
distances to health facility, long waiting times, lack of confidentiality, poor health information 
and poor patient-health provider relationships were the health system factors that negatively 
impacted on ART adherence.  
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Conclusion: The combination and complexity of factors affecting adherence identified in this 
study have posed a challenge to adherence to ART. People have been forced to make 
adjustments to their routine lives in order to accommodate ART. The most problematic factor 
identified was the use of TCAM in combination with ART or as replacement of ART.  
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CHAPTER 1: INTRODUCTION 
1.1 OVERVIEW OF HIV/AIDS EPIDEMIC 
HIV/AIDS remains one of the major public health problems worldwide with the UNAIDS 
(2011) estimating that between 31.6-35.2 million people worldwide were living with HIV/AIDS 
at the end of 2010, and between 2.4-2.9 million new HIV infections, and between 1.6-1.9 million 
AIDS related deaths in that year. Sub- Saharan Africa is the most severely affected region having 
68% of the global share of People Living with HIV/AIDS (PLWHA).  
Zambia is one of the countries hardest hit by the worldwide HIV/AIDS pandemic with a national 
HIV prevalence estimated at 14 % (CSO et al., 2009). One solution to this scourge is the use of 
ART. ART has been proven to reduce the viral load, improve the well-being and consequently 
reduce mortality of PLWHA. The availability of ART has improved the longevity (reduced 
mortality) and improved the quality of life among PLWHA; thereby causing them to live 
relatively normal lives with a chronic disease (UNAIDS, 2010). 
UNAIDS (2011) estimates that at the end of 2010, there were about 1.2 million PLWHA in 
Zambia; of which 350,000 were accessing ART. 
1.2 ADHERENCE TO ANTIRETROVIRAL THERAPY 
While availability of ART has improved lives of PLWHA globally, the lack of adherence to 
Highly Active Antiretroviral Therapy (HAART) still remains a major challenge (Kgatlwane et 
al., 2005).  Remien et al. (2002) showed that individuals with poor adherence to the 
antiretroviral therapy regimen can develop resistant strains and in turn spread the resistant virus. 
Nakiyemba et al. (2002) suggest that the risk of transmission of resistant viruses in communities 
makes adherence a public health concern. Individuals who are not adherent to ART will have 
reduced immunological benefits of ART which can lead to increased HIV-related mortality, 
morbidity and hospitalization (Palepu et al., 2004; Machtinger & Bangsberg, 2005). The 
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emergence of drug resistant strains of HIV would require people to be switched to a more 
complex (second or third line ARVs) and expensive treatment regimen (Bangsberg et al., 2001). 
This will burden already strained national economies especially for developing countries where 
national drug budgets will need to be increased at the expense of other services in order to meet 
the demand for the more expensive second and third line antiretroviral drugs required for those 
with resistant strains (MSF, 2008).  
The World Health Organization (WHO) (2004) suggests that despite patients‟ understanding of 
the consequences of non-adherence to medication, adherence rates were sub optimal across the 
globe. A number of studies mainly from developed countries in the north have established that 
non-adherence rates range from 50%-80% in different contexts (Amico et al., 2005; Remien et 
al., 2007; Weiser et al., 2003). One meta-analysis of adherence to HAART in North America and 
sub-Saharan Africa estimated that only 55% of people in the populations studied achieved 
adequate levels of adherence (Mills et al., 2006a). 
1.2.1 Adherence in Sub-Saharan Africa 
ART adherence studies in Africa have shown mixed outcomes with some showing good 
adherence while others poor adherence. A study conducted in South Africa showed that despite 
the low socio-economic status and the low to mid-levels of education attainment of the study 
population, 88% reported adherence levels of greater than 95% on ART (Nachega et al., 2004). 
Another study in Nigeria showed that only 54% of the patients took at least 80% of the drugs 
prescribed with the main reasons for non-adherence ranging from non-availability of the drugs, 
forgetfulness and lack of funds (Iliyasu et al., 2005). A similar outcome was reported by Weiser 
et al. (2003) in Botswana where 54% of patients attained 95% adherence to required doses. 
1.2.2 Adherence in Zambia 
In Mumbwa, a rural district in the Central Province of Zambia, a cross-sectional survey with 518 
patients reported 88% of them not having missed doses over the period of review (Nozaki et al., 
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2011). An earlier cross-sectional survey in four Zambian rural districts (Chinsali, Mpika, 
Kasama and Mbala) found that 56% of the respondents missed taking their medication in the last 
3 months (Baboo et al., 2005).  
1.3 ANTIRETROVIRAL THERAPY IN ZAMBIA 
Zambia launched her public ART programme in 2002 as a pilot at two health facilities namely 
the University Teaching Hospital (UTH) and Ndola Central Hospital (NCH) (Kombe & Smith, 
2003). Initially, People Living with HIV/AIDS (PLWHA) had to pay a certain amount to access 
ART services. In 2004 and 2005 ART services were rolled out to the remaining 7 provincial 
hospitals at no cost to the patient. Although ART has improved the lives of many in Zambia, 
poor adherence still remains a major challenge to AIDS care (Baboo et al., 2005). 
1.4 PROBLEM STATEMENT 
According to the Hospital Management Information Systems (HMIS), Livingstone General 
Hospital (LGH) has experienced increasing cases of opportunistic infections and TB among 
patients on HAART raising concerns of non-adherence to HAART. Some scholars in Zambia 
have already reported similar concerns (Handema et al., 2003). There have been an increasing 
number of patients that have been changed from the cheaper first line regimen to the more 
expensive second line therapy due to treatment failure and failure to the first line drugs 
undoubtedly will further increase the cost and burden to the state.  
The HMIS at Livingstone General Hospital (LGH) suggests poor adherence among patients 
accessing HAART. The ART statistics for the six month period from January to June 2011 show 
that nearly ten percent (343 out of 3880) patients have missed their monthly refills by two to 
thirty days, implying an adherence level to medication of less than 95%. This adherence might 
be a conservative estimate because it is based on refill data and does not capture whether those 
who actually receive the drugs as per schedule take (swallow) the drugs consistently.   
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It is for this reason that this study was designed to explore the factors that hinder adherence 
among patients on ART in Livingstone where the defaulter rate and those missing refills are 
high. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 INTRODUCTION 
This chapter will review studies about adherence, starting with definitions of adherence and non-
adherence followed by a discussion of factors that affect adherence to ART. 
2.2 DEFINITION OF CONCEPTS 
2.2.1 Adherence 
The World Health Organization (WHO) adherence project adopted the definition of adherence to 
long-term therapy by merging the definitions of Haynes (1979) and Rand (1993). According to 
the definition, adherence is, “the extent to which a person's behaviour - taking medication, 
following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations 
from a health care provider” (WHO, 2003: 3). 
2.2.2 Non-adherence 
WHO (2003) suggests that non-adherence refers to failure to take medication as prescribed, by 
discontinuing medication before completion of the course, taking more or less medication than 
prescribed, or  taking dosages at the wrong times or time intervals. 
2.3 BARRIERS TO ADHERENCE TO ANTIRETROVIRAL TREATMENT 
In this study, the factors that affect ART adherence have been categorized into four main themes 
namely socio-economic, regimen, patient and health service factors.  
A number of key factors facilitating non-adherence to ART have been identified mainly in 
resource rich settings. Some of these are: patient-related factors such as psychological disorders 
(e.g. depression), alcohol and substance use (Bartlett, 2002; Rao et al., 2007), patient-health 
provider relationship (Remien et al., 2007), treatment related factors such as pill burden and 
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complexity of regimen (Bartlett, 2002; Chesney et al., 2000; WHO, 2004), side effects (Bartlett, 
2002; Rao et al., 2007) and patient beliefs (Lewis et al., 2006, Remien et al., 2003). In addition 
to the factors outlined above, studies done in resource limited settings have also reported 
economic factors such as financial constraints, cost of transport and medication as reasons for 
non-adherence (Mills et al., 2006b). 
2.3.1 Socio-economic Factors 
Socio-economic factors such as poverty (transport cost and lack of food), traditional and cultural 
beliefs and religion have been reported to influence ART adherence (McAllister, 2006; Edward 
et al., 2006; Wanyama et al., 2007; Sharon et al., 2006). 
2.3.1.1 Poverty 
Poverty was reported as a consistent barrier to ART adherence in a number of studies and this 
was largely experienced in terms of transport cost to attend health services and lack of food, the 
latter essential to take with the ART medication. Studies conducted by Hardon et al. (2007) in 
Botswana, Uganda and Tanzania, by Thobias (2008) in Namibia and Tuller et al. (2009) in 
Uganda all reported either transport costs or lack of food or both as reasons for non-adherence to 
ART.  Similar findings were reported by Mills et al. (2006b) in a meta-analysis done in both 
developed and developing countries. In Namibia Thobias (2008) reported that patients failed to 
take their medication when hungry or when food was not available because they perceived that 
the medication was too powerful and had detrimental effects when taken on an empty stomach. 
Similar findings were reported by Hardon et al. (2007) when participants reported hunger in the 
initial treatment phase as a challenge to adherence. A study done by Kumarasamy et al. (2005) in 
India also reported transport money as a barrier to adherence. Participants in the studies outlined 
above either reported missing refills because of lack of money to pay for transportation or 
reported having spent the money on other competing needs such as buying food for the family 
rather than going to the clinic for refill.  
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A study done in Zambia by Nozaki et al. (2009) found transports costs and lack of food as a 
challenge to ART adherence. The lack of food was reported to nullify the effects of ART. Food 
scarcity was also identified as a drawback to ART adherence in Tanzania (WHO, 2006). 
However, a study done among women in rural and urban Zambia found different results when it 
was reported that the lack of transport cost did not negatively affect ART adherence as the 
women were determined to seek treatment amidst challenges (Murray et al., 2009). Similar 
findings were reported in another study done in Zambia (Carlucci et al., 2008). 
2.3.1.2 Traditional and cultural beliefs 
The use of traditional medicine and complementary and alternative medicine is generally 
accepted worldwide (WHO, 2002). Remien et al. (2007) suggests that the use of alternative 
therapy was gaining popularity among HIV patients globally and may influence more patients to 
be non-adherent to ART in the future. Traditional medicine in the African context refers to 
various forms of indigenous medicine which include: herbs, animal parts, minerals as well as 
non-medication therapies such as acupuncture, manual therapies and spiritual therapies (Amzat 
& Abdullahi, 2008) which are very common and deep rooted in the health management system 
in Africa. Traditional medicine and complementary and alternative medicine may influence 
adherence to ART as noted in a study conducted in Uganda by Wanyama et al. (2007) where 
patients replaced ART with spiritual therapies believing that they had been cured. Similar 
findings of using complementary and alternative medicine were reported by Peltzer et al. (2008) 
in a study conducted in KwaZulu-Natal, South Africa where it was found that the use of herbal 
therapies continued among patients on ART albeit at a reduction from the initial 36.6% at the 
start to 7.6% at the end of the study. In this study, ART non adherence was found to be 
associated with the use of herbal treatment. Another study conducted by Langlois-Klassen, Kipp 
and Rubaale (2008) in western Uganda reported that 64% of the respondents were using herbal 
medicine in combination with ART after being diagnosed with HIV. Only 16% of these 
participants informed their medical practitioners about using herbs because they knew it would 
not be supported.  
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From the outlined studies above, there appears to be a complex relationship between the use of 
traditional medicine and biomedical medicine in the era of HIV and this has posed a challenge to 
treatment adherence. 
2.3.1.3 Stigma and discrimination 
The UNAIDS (2011: 27) defines stigma as, “a dynamic process of devaluation that significantly 
discredits an individual in the eyes of others” while discrimination is defined as, “ any form of 
arbitrary distinction, exclusion, or restriction affecting a person, usually but not only by virtue of 
an inherent personal characteristic or perceived belonging to a particular group in the case of 
AIDS, a person‟s confirmed or suspected HIV-positive status irrespective of whether or not there 
is any justification for these measures.” Klitzman et al. (2004) suggests that stigma against HIV 
may be a barrier to medication adherence mainly due to the relationship between adherence and 
disclosure. Disclosure in this case is about HIV-infected individuals being open towards others 
about their infection thereby creating an enabling environment for medication intake. When 
patients experience stigma or expect to be stigmatized they will find it difficult to disclose to 
others, which in turn poses a barrier to medication adherence. Similar findings are reported by 
Au et al. (2006) and Uzochukwu et al. (2008) who found statistically significant relationships 
between privacy and adherence in Rwanda and Nigeria respectively. Some participants reported 
lack of privacy in the health setting as a reason for non-adherence in a study done in Botswana 
(Kgatlwane et al., 2006). Patients were concerned about being seen by others taking the drugs 
and thus being identified as HIV positive. Stigma operates at two levels in the above situations. 
Firstly, patients take the medication in the home environment and try to maintain secrecy and 
secondly they attend ART clinics which can also be a form of exposure of HIV status.  As a 
result of this, patients resort to taking their medications in secrecy or avoid situations exposing 
their status (Hill, Kendall & Fernandez, 2003; Meystre-Agustoni et al., 2000). Hardon et al. 
(2007) reported that some ART users, lost their jobs (Tanzania), were abandoned or treated badly 
by partners (Botswana) or were isolated by community members (Uganda) after disclosing their 
HIV positive status. 
2.3.1.4 Religion 
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Religion plays an important role in ART adherence (Wasti et al., 2012).  A study done by Sharon 
et al. (2006) in the United States of America suggests that certain religious practices can affect 
ART adherence either positively or negatively. This can be seen from a cross-sectional mixed 
methods study done by Wasti et al. (2012) which found that a number of Muslim patients had to 
abandon their ART in the mornings during Ramadan because it was deemed sinful to take 
medication with water. Wanyama et al. (2007) reported patients discontinuing their treatment 
because they thought they were spiritually healed while Deribe et al. (2008) reported interruption 
of treatment among patients due to the use of holy water in a study conducted in Ethiopia. In 
contrast, a study done in Tanzania showed that while faith leaders (FLs) believed that prayers 
could potentially cure HIV, ART use was generally not discouraged because it was believed that 
both ART and faith in God played a role in the management of HIV/AIDS (Roura et al., 2010). 
Other studies done by Sanjobo, Frich and Fretheim (2008) and Nam et al. (2008) found that that 
religious beliefs, faith and prayers were associated with better adherence because these helped 
patients to cope with their illness.  
2.3.1.5 Family support, partner support and disclosure 
Bongololo et al. (2005) found that lack of family support posed a challenge to adherence to ART 
among patients because they felt unloved and isolated. Mills et al. (2006) reported similar 
findings when it was reported that patients who disclosed their HIV status to their families and 
close acquaintances had no problems with adherence to ART because they received support 
while those who had not disclosed had challenges adhering to ART.  
Fong et al. (2003) and Godin et al. (2005) suggest that the feeling of hopelessness had a negative 
effect on ART adherence while Marc et al. (2007) suggested that acceptance of the disease and 
development of a positive attitude to ART were facilitators to ART adherence. This shows the 
relationship between support and mental health which will be discussed later in this chapter. 
2.3.2 Regimen Characteristics 
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HAART comprises a regimen of three or more ARVs (mainly two nucleoside reverse 
transcriptase inhibitors (NRTI), a non-nucleoside reverse transcriptase inhibitor (NNRTI) and, or 
a protease inhibitor (PI)) resulting in a complex regimen (number of pills and daily dosage) 
which is life-long (WHO, 2003). The regimen involve high pill burden which in most cases are 
prescribed in combination with other drugs for opportunistic infections (OI‟s) such as 
cotrimoxazole. However, the advent of fixed dose combination (FDCs) has to a large extent 
reduced the pill burden and improved adherence as two or at times three drugs are integrated in 
one pill (Oyugi et al., 2004). This can be noted from a review of results from published clinical 
studies (both randomized and observational) that directly compared twice-daily versus once-
daily regimens and found that adherence was better with the once-daily regimens (Nachega et 
al., 2011). 
2.3.2.1 Dosing schedule 
Dosing schedule has been reported to have an influence on ART adherence. Patterson et al. 
(2000) found that twice daily doses were associated with better adherence than three times daily 
dosing. Similar studies conducted in Senegal and Botswana reported varying adherence levels 
among ART patients depending on the ARV combination they were taking (Laniece et al., 
2003). For example, one patient could be taking a FDC comprising Tenofovir, Emitricitarbine 
and Efavirenz in one pill taken once daily while another would be taking a twice daily regimen 
comprising a FDC of Zidovudine and Lamivudine and a separate dose of Nevirapine twice daily. 
2.3.2.2 Side effects/Adverse drug reactions 
Substantial evidence has linked treatment success to adherence to ARVs while adherence to 
treatment has also been closely linked to adverse drug reactions (Duval et al., 2004; Montessori 
et al., 2004).Antiretroviral drugs (ARVs) have been associated with toxicities and adverse effects 
which range from mild to life threatening with short and long term effects (Hogg et al., 1999). 
Adverse drug reactions such as liver disease, renal insufficiency, peripheral neuropathy, 
lipodystrophy, glucose intolerance, pancreatitis, lactic acidosis, neuropsychiatric disorders and 
Stevens - Johnson syndrome (SJS) can be life threatening (Murphy, 2003; Mills et al., 2006b). 
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Milder effects attributed to these drugs are vomiting, nausea, malaise and diarrhea (Mills et al., 
2006b) which are common to ART patients A study done by Mocroft et al. (2001) found that 
side effects such as diarrhoea, nausea and vomiting caused the most distress among participants. 
Studies conducted in Ethiopia, Tanzania, Botswana and South Africa have shown that one third 
to half of all patients on ART experienced side effects though there was no significant influence 
on adherence (Beyene et al., 2009; Watt et al., 2009; Weiser et al., 2003; Aspeling & Van Wyk, 
2008). The findings could be attributed to the high ART knowledge among respondents involved 
in the studies. In contrast, a study conducted by Abel and Painter (2003) in the United States of 
America (USA) reported that patients who experienced side effects like nausea, fatigue, 
diarrhoea, vomiting and tingling had difficulties taking their medication. These findings are 
similar to those noted by Laurent et al. (2002) where vomiting, nausea, skin rashes, dizziness and 
hallucinations were reported despite taking correct doses of medication. It has been suggested 
that newer FDCs improve adherence but may enhance toxicity and side effects associated with 
HAART (Zeldin & Petruschke, 2004). 
2.3.2.3 Pill burden and complexity of treatment 
The complexity of treatment regimen used in ART is a major factor influencing adherence. 
Almost all patients who are on ART are on a regimen of three or more drugs (Grierson et al. 
2000). In addition, most patients on ART are on cotrimoxazole for Pneumocystis Carini 
Pneumonia (PCP) prophylaxis which adds to the complexity. As complexity of the regimen 
increases (e.g. amount of tablets, frequency of dosing and food or dietary requirements), 
adherence decreases (Glass et al., 2006; WHO, 2003; Golin et al., 2002). Nakiyemba et al. 
(2002) and Williams and Friendland (1997) suggest that patients adherence to a regime declines 
with frequency of dosing and poly pharmacy (e.g. prescribing four different drugs) which both 
add to regimen complexity. Comparing once daily, twice daily, thrice daily and four times daily 
dosing, Claxton, Cramer and Pierce (2001) found that adherence on a once daily dosing regimen 
was higher. No difference in adherence was reported between once daily and twice daily 
regimens while a thrice daily regimen was found to be the strongest predictor for non-adherence 
(Orell et al., 2003). 
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Biadgilign et al. (2008) report similar findings when they found that most caregivers and health 
care workers across countries stated that heavy pill burden was a cause of poor adherence to the 
medication regimens.  A study conducted by Weiser et al. (2003) in Botswana found that 30% of 
the patients believed that they had to swallow too many pills per day, though adherence 
challenges were only reported among 5% of patients. This is in contrast with an earlier study 
done by Ickovics and Meade (2002) in developed countries where pill burden was reported to 
negatively influence adherence. 
2.3.3 Patient Characteristics 
Patient characteristics found to influence adherence include: age and gender, alcohol and other 
drug use, literacy/educational levels, mental health, patients‟ forgetfulness and daily schedules. 
2.3.3.1 Age and gender 
Earlier publications such as those published by Sarna et al. (2008), Marc et al. (2007) and Singh 
(1996) found no evidence that age and gender influence ART adherence. However, recent 
studies have found associations between gender and adherence. Puskas et al. (2011) conducted a 
literature review of original research articles on adherence to antiretroviral therapy (ART) in 
developed countries, covering January 2000 to June 2011 to determine if gender differences exist 
in the prevalence of non-adherence to ART. Despite the challenge of comparing articles due to 
the varied reporting strategies, women generally exhibit poorer adherence than men. It was found 
that 30 of the 44 articles (68.2%) that reported comparative data on adherence by gender found 
women to be less adherent than men. Ten articles (17.5%) also showed significant differences in 
proportional adherence by gender, nine of which showed women to be less adherent than men. 
2.3.3.2 Alcohol and other drug use 
Alcohol abuse has been identified as an important barrier to ART adherence in Tanzania, 
Botswana and Uganda by community and health care workers (Remien et al., 2002; WHO, 
2006). Similar findings have been reported by patients in Botswana when 37% of persons with 
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HIV infection indicated that alcohol use influenced their ART adherence (Kip, Ehlers & van der 
Wal, 2009).  
2.3.3.3 Literacy/educational level 
Studies conducted to determine the effects of literacy/educational levels on adherence have 
reported contrasting results. Sanjobo, Frich and Freithman (2008) and Golin et al. (2009) suggest 
that the level of education is not a reliable predictor of adherence to ART. Contrary to the 
findings above, Kip, Ehlers and Van der Wal (2009) reported that patients in with low formal 
education in Botswana were poorer at adhering to medication due to their inability to read and 
follow instructions. This was also reported by Wolf et al. (2007) who noted that poor patient 
literacy was associated with more than three times greater likelihood of missed doses in 
Louisiana and Illinois. Similar findings in the same cities were reported by (Waite et al., 2008). 
On the other hand, a study done by Graham, Bennett, Holmes and Gross (2007) in Philadelphia 
suggests that higher levels of literacy were associated with a more than 95% adherence rate 
implying that those who attain a certain level of education/literacy better adhere to medication. 
However, a study conducted in Cote d‟Ivoire reported a higher level of adherence amongst 
patients with low formal education (Eholie et al., 2007). 
2.3.3.4 Mental Health 
Mental health (e.g. mental depression) has been found to be associated with HIV/AIDS. 
Evidence that mental health status, specifically depressive illness, plays a role in treatment 
adherence has been reported (Seldjeski, Delahanty & Bogart, 2005). Depression may occur in 
individuals suffering from HIV, especially as they adjust to the fact that they are no longer the 
healthy persons they were previously (Simpson, 2006; Zuurmond, 2008). This was also reported 
by DiMatteo, Lepper and Croghan (2000) that among general medical patients, depressed 
patients were three times less likely to adhere to medical treatment than non-depressed patients. 
A study done by Fong et al. (2003) among Chinese PLWHA found that hopelessness and feeling 
overwhelmed by the disease, its prognosis and management had negative effects on adherence in 
ART. Similar findings were reported by Godin et al. (2005) in a study involving PLWHA in 
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Canada. On the other hand, acceptance of the disease and development of a positive attitude to 
ART are facilitators to ART adherence (Marc et al., 2007). 
2.3.3.5 Patients’ forgetfulness 
A report from WHO (2006) indicates that forgetfulness was the most common reason cited by 
those who had problems with adherence to their medication. Patients on ART cited various 
factors such as work, travelling for work, home tasks or attending social events as factors that led 
to forgetfulness (WHO, 2006; Wroth & Pathman, 2006; Simpson, 2006; Heckman, Catz, Miller 
& Kalichman, 2004). Mills et al. (2006a), in a meta-analysis of 58 studies on adherence to ART 
in sub-Saharan Africa and North America reported forgetfulness as a key barrier to ART 
adherence. Similar to the findings of the meta-analysis, Kagee et al. (2007) reports forgetfulness 
as a barrier to ART adherence among primary care patients in a historically disadvantaged 
community in South Africa. 
2.3.3.6 Daily schedule 
Golin et al. (2002), Fong et al. (2003) and Watt et al. (2009) suggest that patients with consistent 
daily schedules found it easier to take their medication thereby facilitating adherence while 
unstable lifestyles and busy work schedules were reported to be barriers to adherence. 
2.3.4 Health Services Factors 
Health service factors such as long waiting times, long traveling distances to the health facilities, 
poor or sound patient-provider relationship, negative staff attitudes, staff shortages and low staff 
motivation have been reported to influence adherence (WHO, 2006; Nakiyemba et al., 2002; 
Zuurmond, 2008). 
2.3.4.1 Long waiting times 
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Quality of services such as clinic hours and waiting times has been found to influence adherence. 
Patients who have to travel long distances have a very narrow period in which to reach the clinic 
on time if the ART service is only provided up to mid-day (WHO, 2006). Those who arrive in 
the afternoon would not receive care. Such short clinic sessions also implies that there is limited 
time for patients to be attended to thereby increasing chances of compromising the quality of 
services provided by the service providers (WHO, 2006).  
Long waiting times at clinics were reported in studies done by WHO (2006) and Zuurmond 
(2008). These delays resulted from health workers being over worked, leading to a delay in the 
provision of health services. This was reported as particularly frustrating since some patients are 
only given limited time from employers to attend the clinic. Similarly studies conducted by 
Hardon et al. (2007) in Botswana, Tanzania and Uganda found that long waiting hours may 
discourage patients from going to clinics and therefore impact on ART adherence. 
2.3.4.2 Distance from health facilities 
ART patients in Botswana reported that they had to travel long distances of up to 200 kilometers 
to reach the nearest health facility. This in turn hampered patients in accessing ART treatment 
(Nachega et al., 2007). 
2.3.4.3 Patient-Health Provider relationship  
The patient-provider relationship has been reported to have an influence on adherence to ART. 
The importance of a strong patient-provider relationship has been emphasized by Murri et al. 
(2004) who suggest that interventions to enhance adherence should include strategies to improve 
the relationships between patients and their attending health providers. Additionally, Jahng et al. 
(2005) suggests that when physicians and patients communicate and agree on how involved 
patients should be in their care, adherence is improved. A study conducted in Mozambique by 
Groh et al. (2011) showed how poor relationships and conflicts with health workers impact 
adherence with male participants identifying lack of confidentiality and poor treatment by 
hospital staff as a major concern. Beyene et al. (2009) suggests that patient satisfaction in the 
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patient-provider relationship was associated with better patient adherence while patient distrust 
was associated with poor adherence. Similarly, a study by Weiser et al. (2003) found that being 
treated with dignity and respect by health care workers resulted in 96% adherence among 
patients. 
2.4 SUMMARY 
The literature review to date has revealed a diverse range of barriers to adherence of ART from 
socio-economic, regimen, patient, and health services related factors. 
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CHAPTER 3: METHODOLOGY 
3.1 INTRODUCTION  
This chapter describes the methodology employed in this study. It outlines the aim and 
objectives, study design, description of research setting, study population and sampling, data 
collection and analysis, rigour and ethical considerations. 
3.2 AIM AND OBJECTIVES 
The aim of the study was to explore barriers to medication adherence in Antiretroviral Therapy 
(ART) among patients attending at Livingstone General Hospital (LGH), Zambia.  
The objectives of the study were: 
 To explore patients experiences, perceptions and understanding of taking ART.  
 To explore patient level factors that influences medication adherence. 
 To explore health systems factors that influences medication adherence. 
 To explore regimen related factors that influences medication adherence. 
 To explore socio-economic factors that influence medication adherence. 
3.3. STUDY DESIGN  
An exploratory study design was used to explore barriers to adherence to ART among patients. 
This design employed qualitative methods to gain familiarity with the phenomenon (adherence) 
at individual level, health service and community contexts. The qualitative method has been 
found to be effective in gathering in-depth information about human experiences that helps us 
understand reasons for certain behavioral patterns (Sankar et al., 2006). Qualitative research also 
allows you to explore a phenomenon within the social environment in which it happens and from 
the patients‟ perspective. 
 
 
 
 
18 
 
3.4 DESCRIPTION OF RESEARCH SETTING 
Livingstone is situated in the Southern Province of Zambia with a population of approximately 
160,000. It is the tourist capital of Zambia. It is mainly urban with a few surrounding rural areas. 
The hotel industry and cross border trade are the main sources of employment.  
According to the Zambia Demographic Health Survey (ZDHS) (CSO et al., 2009), the 
prevalence of HIV among the patients attending the hospital is 31%. Livingstone has ART 
services at both primary and secondary health care levels. There are four (4) primary health care 
facilities, two (2) private clinics and one secondary hospital (LGH) providing ART services. 
LGH draws patients from wide radius and patients could attend from as far as 70 km away.  
The multidisciplinary ART team at Livingstone General Hospital (LGH) comprises of medical 
officers (MO), pharmacists, clinical officers (CO), nurses, biomedical scientists, data associates, 
adherence counselors, peer educators and registry clerks. The medical officers (doctors) and 
clinical officers are responsible for screening and deciding the patients‟ treatment plan. The 
nurses are responsible for taking vital signs (temperature, blood pressure) and also taking of 
patient‟s blood for laboratory tests. Registry clerks are responsible for filing and placing 
laboratory results in patient files. Peer educators give health talks, adherence counseling and 
assist in defaulter tracing in the community. Adherence counselors have a primary role of 
ensuring a one-on-one contact with patients for adherence sessions although at each point of 
contact (from MO to Pharmacist) adherence counseling is addressed. The clinic also has 
volunteers who perform multiple tasks like filing, locating missing patient files and filing 
laboratory results in patient files.  
3.5 STUDY POPULATION AND SAMPLING 
The study population comprised adult patients (women and men older than 17 years) attending 
the ART clinic and accessing ART at Livingstone General Hospital.  
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 According to Rice and Ezzy (1999), sampling in qualitative research targets information rich 
cases for in-depth study. In order to achieve this, qualitative research employs purposive 
sampling. Chopra and Coveney (2003) suggest that the purposive sampling method is the type in 
which the researcher‟s judgment is used to decide which study units should be included in a 
study sample.   
A two stage recruitment and consent process was followed.  After gaining access to the clinic the 
researcher worked closely with a registry clerk working at the ART clinic to recruit participants 
for the study. The clerk was trained on how to identify patients that meet the inclusion criteria 
(age above 18 years, months/years on ART, gender). The patients were identified and 
approached by the clerk during their regular clinic visit and the study was explained. After a 
brief explanation about the study the patients were asked if their contact details could be 
forwarded to the researcher. If patients agreed they were requested to fill in a „consent to be 
contacted by the researcher‟ form (Appendix 1) with their details. Whenever a patient declined 
or indicated no interest, the next eligible patient was approached. The contact details were 
forwarded to the researcher and the 2
nd
 stage of recruitment was done by the researchers who 
contacted the participants and more formal arrangements for both the focus group discussions 
and individual semi-structured interviews were done. Informed consent (Appendix 9) was only 
taken by the researchers once they met and informed the participants about the study using the 
participant information sheet (Appendix 2). 
In this study, purposive sampling was employed to ensure maximum variation among the study 
sample. The inclusion criteria included treatment status and gender. Both male and female 
patients who were treatment naïve (starters less than 6 months on ART), experienced (more than 
one year but less than 3 years on ART) and chronic (greater than three years on ART) with 
varying experience were covered.  
A total of 42 male and female patients participated in the study. All the 42 participated in the 
FGDs while seven (7), who exhibited a high level of understanding on the subject participated in 
the follow up semi-structured interviews (due to data saturation). 
 
 
 
 
20 
 
3.6 DATA COLLECTION  
Focus group discussions and semi-structured interviews were used to collect data. A standard 
FGD guide (Appendix 3) and semi-structured interview guide (Appendix 5) developed by the 
researcher and research assistant were used during the individual interviews and group 
discussions. These were reviewed by the research supervisors to ensure the guides met the study 
objectives and also to ensure uniformity across all groups and individuals. The FGDs and semi-
structured interview guides comprised open ended questions which explored various aspects of 
patient‟s experiences of adherence to ART while addressing the aim and objectives of the 
research. Probes were developed for each of the questions on the guide to ensure clarification 
and further depth of information from the participants or in order to obtain different perspectives 
to the same question (Kitzinger, 1995). 
 
3.6.1 Focus Group Discussions 
A total of six FGDs (3 male and 3 female) were conducted. All FGDs took place in two hospital 
conference rooms away from the ART clinic. These took place between 30 December 2011 and 
24 January 2012.  
3.6.2 Semi structured interviews 
Individual semi-structured interviews were conducted that lasted between 20-30 minutes. A total 
of seven (7) individual interviews were conducted. Some interviews were synchronized with the 
patient‟s appointment date while others were not. The interviews were conducted in one of the 
well-furnished and air conditioned hospital conference rooms away from the ART clinic. All the 
interviews were audio-recorded using a recording device while the interviewer took field notes. 
The purpose of the recording was to ensure that any information missed by the researcher when 
taking field notes was captured. The interviews were conducted in English with certain 
clarifications made in the local language (Tonga and Nyanja). Participants were encouraged to be 
as open as possible and use any language they could express themselves better. 
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3.7 DATA ANALYSIS 
Marshall and Rossman (1995) define data analysis as the process of bringing order, structure and 
meaning to the mass of data collected. This study employed the thematic content analysis 
technique. All taped interviews and FGD were transcribed verbatim within two (2) days after 
each interview and FGD to prevent data loss prior to analysis. The first three individual 
interviews and first FGD were transcribed verbatim and sent to the supervisor to confirm the 
quality of data collection before proceeding with the remaining FGD and individual interviews.  
Once the data was collected, transcripts for both FGD and SSI were read while noting similar 
topics. These were then grouped into major topics or themes. Preliminary data analysis was 
commenced as soon as data collection started (interviews and FGD). This ensured the early 
identity of new emerging themes which allowed adjustments to the interview guide and also 
assisted in the identity of data saturation. Analysis of the FGD and semi-structured interviews 
followed the stages of thematic analysis which are familiarization, theme identification, coding, 
indexing, charting, mapping and interpretation (Pope, Ziebland & May, 2000). Familiarization, 
which means getting grounded into the data collected, was achieved by repeatedly reading the 
transcribed recorded tapes and field notes after which key words and ideas were recorded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Terre Blanche, Durrheim and Painter (2006) suggest that familiarization allows the researcher to 
know what kind of interpretation would most likely be supported by this data. During the 
identification stage, key emerging ideas and words from the familiarization stage were recorded 
from which the researcher identified all the key issues, concepts and categories, and sub 
categories and they were then grouped together. This was done by keeping close to the study 
objectives and from views and experiences that recurred in the data collected.  The key issues 
emerging from the process were identified with repeated words and phrases. Similar topics were 
grouped and arranged into major topics which were noted down into codes, themes and 
subthemes. Finally, factors that influence adherence to ART were identified and grouped into 
main categories. 
3.8 RIGOUR 
3.8.1 Credibility  
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Credibility was ensured through triangulation of data sources and data collection methods. 
Triangulation between the data from the FGDs, semi-structured interviews and researcher field 
notes were sought by seeking for convergence in the data. Convergence in the data was also 
sought through the use of the sampling and eligibility criteria for participant selection for both 
the semi-structured interviews and FGD. Similarly the convergence of the data with the literature 
was further evidence of credibility of the data. Furthermore, similar questions were asked to all 
FGD and individual interview participants to ensure uniformity across all groups. The FGD and 
individual interview processes were explained to participants clearly and discussions were 
transcribed verbatim. To further ensure credibility, the coding process was also done by another 
person (supervisor) which was a validation process of the analysis of the data. 
3.8.2 Trustworthiness 
Trustworthiness was achieved by developing an interview guide that was grounded in the 
literature. Furthermore, the confidentiality that was ensured by the use of coded names for the 
participants with their true identities kept secret strengthened trustworthiness. All FGD and 
individual interviews were conducted in English with clarifications in the local language (Tonga 
& Nyanja) by the same moderator (familiar with the local languages) using the same FGD guide 
and semi-structured interview guide to reduce investigator bias. Participants were informed that 
they could use any language they were comfortable with to allow them to feel comfortable in 
expression themselves. 
3.9 ETHICAL CONSIDERATIONS 
Permission to conduct the research was obtained from the UWC Senate Higher Degrees 
Committee, UWC Senate Research committee (Appendix 6), Southern Provincial Medical Office 
(Appendix 7) and Livingstone General Hospital (Appendix 7). Voluntary participation to this 
study was ensured while indirect benefits to the study were explained to participants prior to 
obtaining written consent. Before each interview, the participant information sheet was read 
through  in the hearing of all participants who after agreeing to participate in the discussion had 
to give informed consent both in written and verbally. Participants were informed that they were 
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free to withdraw from the study at any time they felt like.  The participant information sheet 
comprised a section stating that a recording device would be used in data collection. Participants 
were assured the recording was entirely for the purpose of the verifying, clarifying and ensuring 
all the information they provided was accurate. 
Anonymity and confidentiality were strictly adhered to by assigning numbers to participants 
rather than actual names. Both raw and processed data are kept under lock and key and 
transcripts protected by a password.  
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CHAPTER 4: RESULTS  
4.1 DESCRIPTION OF PARTICIPANTS 
A total of 42 patients participated in the study of which 23 men participated in three male focus 
group discussions from which four were identified for follow up in the semi-structured 
interviews. The average age of the men was 43 years of which nine have been on ART for more 
than three years and another nine on ART from one to three years. Similarly 19 women 
participated in the three female FGD most (11) of whom had taken ART for more than three 
years. Three women were followed up with semi-structured interviews. Most of the participants 
were not employed and had an average education level of secondary school. Most of them lived 
about 10 km from the clinic. 
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Table 1: FGD participants 
FGD Sex Age Educational 
Level 
Years on ART Marital 
Status 
1 M 34 Secondary Between 1 & 3 years Married 
 M 50 Secondary > 3 years Married 
 M 45 Primary > 3 years Married 
 M 45 College > 3 years Married 
 M 46 None > 3 years Married 
 M 36 Secondary Between 1 & 3 years Married 
 M 41 College > 3 years Married 
 M 40 College Between 1 & 3 years Married 
 M 60 College > 3 years Married 
 M 43 Secondary Between 1 & 3 years Married 
      
2 F 39 Secondary > 3 years Single 
 F 33 Primary > 3 years Married 
 F 38 Primary > 3 years Single 
 F 28 College > 3 years Married 
 F 47 Secondary > 3 years Married 
 F 39 Secondary Between 1 & 3 years Married 
 F 33 College Between 1 & 3 years Married 
      
3 M 31 Primary < 6 months Married 
 M 55 Secondary Between 1 & 3 years Single 
 M 49 Secondary > 3 years Married 
 M 47 Secondary < 6 months Married 
 M 34 University Between 1 & 3 years Married 
 M 41 Secondary Between 1 & 3 years Married 
      
4 F 21 Secondary < 1 year (7 months) Single 
 F 46 Secondary > 3 years Single 
 F 44 Secondary Between 1 & 3 years Single 
 F 41 Secondary > 3 years Single 
 F 29 Secondary < 1 year (9 months) Married 
 F 35 Primary > 3 years Single 
      
5 M 35 Primary Between 1 & 3 years Married 
 M 45 College < 6 months Married 
 M 48 Secondary Between 1 & 3 years Married 
 M 32 College > 3 years Married 
 M 50 Secondary < 6 months Married 
 M 42 College > 3 years Married 
 M 45 College > 3 years Married 
 
 
 
 
26 
 
      
6 F 50 College > 3 years Married 
 F 47 Secondary > 3years Single 
 F 25 College > 3 years Married 
 F 42 Secondary < 1 year(9 months) Married 
 F 37 College > 3 years Married 
 F 34 College > 3years Single 
  
Table 2: Semi-structured Interview participants 
SSI Sex Age Educational 
Level 
Years on ART Marital 
Status 
1 M 43 Secondary Between 1 & 3 years Married 
2 M 34 Secondary Between 1 & 3 years Married 
3 M 45 Primary > 3 years Married 
4 F 28 College >3 years Married 
5 F 37 College > 3 years Married 
6 F 34 College > 3years Single 
7 M 45 College < 6 months Married 
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4.2 THEMES 
The main themes that emerged from analysis of FGDs and individual interviews with ART 
patients were: economic factors, social factors, regimen characteristics, patient characteristics 
and health services factors.  
Table 3: Classification of themes 
THEMES SUB THEMES 
1. Economic factors 1.1 Poverty and unemployment 
 1.1.1 Lack of food 
 1.1.2 Transport cost 
 1.2 Nature of employment 
2. Social factors 2.1 Traditional and cultural beliefs 
 2.2 Stigma and discrimination 
 2.3 Religion 
 2.4 Family support, partner support & disclosure 
3. Regimen Characteristics 3.1 Side effects 
 3.2 Pill burden and complexity of treatment 
4. Patient Characteristics 4.1 Alcohol use 
 4.2 Literacy/educational levels 
 4.3 Forgetting to take medication 
 4.4 Disclosure and non-disclosure of HIV status 
5. Health service factors 5.1 Staff attitude 
 5.2 Counseling  
 5.3 Lack of confidentiality  
 5.4 Long waiting times  
 5.5 Distance from ART clinic  
 5.6 Poor health information  
 5.7 Patient- Health Provider  relationship  
 5.8 Skills and staff competences 
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4.2.1 Economic Factors 
4.2.1.1 Poverty and unemployment 
Poverty and unemployment emerged as very important socio-economic barriers to adherence in 
all focus group discussions and semi-structured interviews. Lack of income among participants 
meant that most were unable to either buy food or afford transportation costs to the ART clinic. 
Most participants of the FGD and semi-structured interviews were not in any form of 
employment. Despite the challenges some patients managed to adhere to treatment while others 
did not thereby affecting ART adherence. 
A male participant in particular who had a family to care for spoke of the difficulties of securing 
meals for himself and his family. 
“Like me … I‟m not working. It is hard to meet the demands for home. Food on the table is hard. 
Sometimes you just eat breakfast no lunch and supper or supper but no lunch. It‟s hard.” [Male 
34 years] 
Not having money to travel to the clinic for clinical visits and drug refill was also reported as a 
barrier to ART adherence. 
“I stay far so I always have to look for money to come. I stay in Kazungula which is about 70 km 
away from here. It‟s a problem to come here.” [Female 42 years] 
4.2.1.2 Lack of food 
Participants acknowledged the importance of food to ensure maximum adherence. Lack of food 
did not just create problems for the accompaniment of the drugs, but poor nutrition also 
interacted with the ART drugs resulting in bodily responses such as increased appetite and this 
was often perceived as the drugs being „powerful‟. 
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“If food is little, these drugs give appetite, they are powerful. If you are not strong you can stop 
taking them.” [Male 34 years] 
“Hunger is the biggest problem.  Many don‟t work and the medication we take is powerful. It 
would be good if it can be looked into then things will be better for others.” [Male 41 years] 
“Food is a big challenge. Where do you find food? It‟s expensive and we are not working.” 
[Female 47 years] 
“You have no food; so people are fearing to take these drugs. I don‟t know what you can do. I 
don‟t work…. If we would be given food that would help. That‟s why a lot of people stop drinking 
their medicines.” [Male 32 years] 
“Food is a problem. You have no food eat at that time but you need to take your drugs.” [Female 
47 years] 
4.2.1.3 Nature of employment 
Some of those that were employed explained how the nature of their employment affected their 
ability to adhere to the drugs. For many it was related to not receiving supplies of drugs that 
could cover long periods away from the clinic.   
“…. I‟m a journalist. You are out for weeks, months. For you to come back you cannot you find 
your due date finds you in another place.” [Male 34 years] 
“Like he has said. I‟m a businessman when time comes you are out. So you fail to collect your 
drugs.” [Male 31 years] 
“There is a young man who got employed as a casual worker and when he went he did not take 
enough supplies. He did not have drugs for about two months and he came back shaking and 
staggering. He had to be restarted on the drugs.” [Male 50 years] 
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4.2.2 Social Factors 
4.2.2.1 Traditional and cultural beliefs 
Traditional beliefs about the use of alternative therapies were reported as barrier to ART 
adherence. The taking of alternative therapies was a common practice and participants expressed 
mixed opinions on the merits of its use either alone or in combination with ART. None of the 
participants reported replacing ART for alternative treatment or non-adherence to ART, but gave 
accounts of acquaintances using alternative treatment.  
One male participant reported being informed on the role of traditional medicines in HIV 
treatment. 
“There are some herbal medicines but we don‟t know their names. They drink sometimes on 
table spoons, others bath this herbal medicine. When you bath or drink people say the virus 
dies.” [Male 41 years]. 
Another male participant who has been on ART for between one to three years reported how he 
combined his ART medication with traditional medicine. 
“Yes so far so good. You take it with tea or any foodstuff. In food you put one teaspoon. It has 
worked. Immediately I started using it the CD4 improved.” [Male 36 years]  
Another man said people were encouraged to take ART in combination with traditional 
medicine.  
“Combine herbs, immune boost, combine with ARVs, no effect on ARVs.” [Male 34 years] 
Except for the above participant few were prepared to talk about their own experience and most 
spoke about what they had heard and seen others do. It was clear that not all supported 
alternative therapy. A participant reported that people who were convinced to stop their ARVs 
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for the traditional medicine from the Moringa tree leaves (leaves are dried in the shade) have 
now realized that the tree does not cure.  
“Most of the clients have stopped taking ARVs because of this advice. A lot of people have now 
seen the tree can‟t cure.” [Female 44 years] 
A number of participants reported how acquaintances had abandoned ART for traditional 
medicine. 
“I had a friend who I did not see come for three months for ARV collection, when we met he told 
me he was taking something else.” [Male 32 years] 
“One time a friend of mine missed and when I asked him he said the mother in Lusaka had given 
him traditional medicine. I have not followed up.” [Male 45 years]. 
“Here people are saying there is „Back to Eden‟ (herbs) so I have a friend who is refusing to 
take ARVs even his children. He is promoting herbal things. When I looked at his children he has 
mental problem because of using Back to Eden.” [Male 41 years] 
The origin of the traditional medicine was not always from within Zambia with participants 
attributing non-adherence to ART due to the availability of traditional medicine from within or 
outside Zambia being sold in the streets of Livingstone and Lusaka towns. 
“There is medicine on sale in the corridors of Livingstone. That should be the medicine not 
making people come early (seek help early). It‟s from abroad. This medicine is said to cure HIV. 
People are buying it at the expense of ARVs.” [Male 49 years] 
“I‟ve been hearing people when collecting drugs that there is medicine in Lusaka going for 
300,000 kwacha one tablet which if you drink and then after some time you go for a test you will 
be negative. They give you a certain number of tablets.” [Female 35 years] 
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A common alternative therapy that people in this area are advised to take and which was 
discussed by many is crocodile fat.  Participants had different experiences and opinions on its use 
as an alternative to ART. 
“You have to drink it and when you drink it at last you will be ok.”[Female 21 years] 
“Namwala they are using crocodile fat. When I checked on someone using this fat his health is 
not good unlike me who is on ARVs. He has rashes all over his body.” [Male 50 years] 
4.2.2.2 Stigma and discrimination 
Stigma and discrimination were prominent during the focus groups discussions and semi-
structured interviews for both males and females. Stigma and discrimination in itself did not lead 
to non-adherence but the taking of drugs (ARVs) exposed their HIV status and this led to stigma. 
Most participants who spoke about stigma in this context reported discouragement. Nevertheless, 
in all cases participants were able to cope and did not report any non-adherence. 
“In society, others neglect us when they hear you are on ARVs. They don‟t even want to sit where 
you sit. They point at you that one is sick. You can even tell that those are talking about you. You 
feel lonely. You get tempted to feel negatively about yourself. You feel like stopping taking your 
drugs.” [Female 47 years] 
“Apart from nick naming, once community knows you are HIV positive they lose confidence in 
you.  Some think that person won‟t see the next day. They leave you out. Even in family matters 
you are left out. They saying, uyu aza fa maje manje musiyeni chabe. {This person will die soon 
just leave them} There is that stigma and this is discouraging.” [Male 41 years] 
Stigma and discrimination were also reported to be a problem at places of work especially for the 
participants in formal employment. A male participant reported that insurance was not a priority 
for the HIV positive persons at his place of work. 
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“To start with even when it comes to insurance they require you to declare your status. If you 
are positive they won‟t give you insurance.” [Male 34 years] 
“Like at work. The time I started getting sick they terminated my job from last year. They 
thought I would die or something like that. After I started taking medicine and was better I went 
to claim my salary and benefits. They were surprised and said, ah you got well. They asked me 
when I was getting back to work but I told them I am not coming just give me my benefits. I was 
working at a pre-school and so I would be told parents are complaining at the way you appear. 
When you cough they would say all sorts of things like you will spread it.” [Female 21 years] 
The experience of being laughed at by community members was a common theme discussed by 
participants and they explained how it could negatively impact adherence. 
“We are laughed at. We just have to be strong.” [Female 28 years] 
Discrimination was also reported at family level. 
“Yes, our families also abandon us. Blankets you have your own, clothes even drink in the same 
cup, and eating together, you can‟t. Once you are discovered to be taking drugs, people don‟t 
consider you.” [Female 39 years] 
“In some villages, immediately they know (HIV status) you will be cut off immediately depending 
on where you come from. They can even kill you using magic. So it becomes difficult to take 
before your relatives because of this.” [Male 50 years] 
However a few accounts of support from family and partners were reported and such support 
assisted and served as motivators to adherence for some participants. 
“My children help to remind me to take my drug.” [Female 34 years] 
“In our families when they know they support like my boy. When it‟s 21:00 hours he tells me, 
daddy it‟s time to take your drugs.” [Male 45 years] 
 
 
 
 
34 
 
4.2.2.3 Religion 
Religion was also reported to be used as an alternative or combination with ART. During the 
group discussions and interviews, religious beliefs, faith healing and church leaders‟ advice came 
out as a prominent barrier to adherence to ART. Most participants reported knowing or hearing 
about one who was advised to stop ART by church leaders if they were to rid themselves of the 
HIV. Some participants further reported knowing or hearing about individuals who had sought 
help and had been prayed for by a renowned pastor but were still not healed or had died. 
“Concerning religion, so many have died because of being cheated by pastors telling them just 
to have faith and they will be okay. I have seen two or three die because they believed pastors 
and stopped taking their drugs.” [Male 45 years] 
 “This issue we are talking about ARVs one woman is sick right now. My neighbor. She went to 
church and was told she was healed and threw away her ARVs. She came back and is not healed. 
She got very sick and now she is back on ARVs.” [Male 31 years] 
Participants explained how people were encouraged to abandoned ART when priests told them; 
 “He who has faith can go and throw away ARVs and get healed.” [Male 50 years] 
“If you take ARVs and you want to be prayed for then you have no faith so if you want healing 
stop ARVs.” [Female 33 years] 
However the role of the church and religion was not all negative and prayer at the start of the 
clinic was considered important. This was suggested by people who seem to be also illiterate and 
although they had faith in the ART they also needed to combine the medical therapy with their 
religious beliefs and it was suggested that the clinic start with singing of church hymns. One 
female participant who has been on ART for more than 3 years believes that she had seen 
evidence of the power of prayer.  
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“Prayers and anointing oil can heal you. I had a sister she took ARVs for 9 months and she 
stopped. She is just okay up to now she is not taking them.” [Female 37 years] 
One participant acknowledged the assistance given to her by church leaders. 
“When I have no transport money the church through pastor and the wife assist me as they know 
my situation. I have disclosed to them so accessibility is not a problem.” [Female 34 years] 
4.2.2.4 Family and partner support 
Some participants who had opened up to their families reported easy adherence due to support 
from spouses and children. While others found it easy to disclose, some felt that disclosing to 
their children was not in order. Furthermore, others reported victimization from spouses upon 
disclosure. 
“It is hard to tell children because when you do this they can think you will die tomorrow.” 
[Female 34 years] 
“After disclosing I was still troubled. When taking medication I was hiding and had to be in a 
private place. My wife was so annoyed and she started blaming me that I was the one who will 
cause her to get sick. We had serious problems and our marriage almost ended.” [Male 34 
years] 
“When I disclosed my wife was upset and she decided to leave me.” [Male 45 years] 
“Even the first time I came for my test I told them. My brother in law encouraged me to come for 
the test. He works at the hospital. He counseled me. I told everyone then I started my medication. 
My children, dad and mum know. To my family disclosure was easy but friends when you tell 
them they would keep a distance. Before disclosing you feel you are carrying something heavy. 
Now at least my friends know and have accepted. This has made it easy for me. Some even refuse 
to believe that I‟m positive when I tell them. I can even take it in the presence of my friends. I can 
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even call my child to bring my medicine. If you don‟t disclose and people are around you, you 
can‟t take you drugs so you need to disclose.” [Female 28 years] 
“I‟ve disclosed to my family both my wife‟s and mine. This disclosure makes it easy for me to 
take my medication. We remind each other.” [Male 45 years] 
4.2.3 Regimen Characteristics 
4.2.3.1 Side effects 
Participants mentioned a number of side effects that they‟ve experienced whilst on ART. Many 
of the participants were able to link side effects to a drug and the names were often mentioned. 
Participants own experiences of coping with the side effects were reported. Those who had been 
on ART for more than one year reported coping better than those on ART for a lesser period. 
“It‟s not easy but with time it‟s bearable. It depends on an individual. One can adapt and keep 
on.” [Male 45 years] 
Most of the side effects occurred at the start of ART but gradually reduced with time. These 
included common side effects such as nausea, diarrhoea, vomiting, numbness, palpitations, 
nightmares, dizziness, drowsiness, stomach pains, constipation, body weakness and loss of 
appetite. Some uncommon side effects experienced by participants were slight visual 
impairment, body shape changes especially in females, swelling of legs, intermittent loss of 
memory, paralysis and Nevirapine induced rash.  
“Yes the same drug he is talking about, it‟s affecting me. My sight is affected and this is 
disturbing. The way we are sitting here I see dark dark.” [Male 49 years] 
“I have also developed a hump on my back. So I don‟t know which right medicine I‟m supposed 
to take. Taking drugs like this is not encouraging.” [37 year old female] 
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“First I was on Triomune 30. The way I looked I was skinny and my bums were finishing. I was 
looking skinny.”[Female 40 years] 
“The first time I started taking ART my legs started swelling.”[Female 35 years] 
“I did not react well to Nevirapine. Rash was all over my body.”[Female 40 years] 
“Sometimes I lose memory. When I go to something I forget. Since I started ART it has been 
bad.”[Female 33 years] 
Some participants also mentioned having side effects such as headaches and loss of appetite 
when they missed some doses of their medication while others mentioned experiencing side 
effects such as stomach pains, vomiting and tremors after taking ART without food. Some 
participants also agreed that the drugs were powerful through the impact of the side effects. 
“Those tablets really make me weak.” [Female 50 years] 
4.2.3.2 Pill burden and complexity of treatment 
Most participants had a concern on the number of pills taken per day. This is because in addition 
to ART, most of them also have to take cotrimoxazole for Pneumocystis Carini Pneumonia 
(PCP) prophylaxis. They provided many recommendations for new technology and new drugs to 
reduce the pill burden. The commonest recommendation was having an injectable form of ARVs 
similar to that of family planning preparations where one would just need one dose for three 
months. Others suggested being changed to the newer product which has three drugs in one 
tablet and is dosed once daily. 
“If there could be an injection for 3 months like the family planning for women it would help.” 
[Male 41 years] 
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“In the community, people are saying the government should think of changing to injections and 
not tablets because of forgetting to take their tables. This will help people stop missing their 
medicines.” [Male 47 years] 
4.2.4 Patient Characteristics 
4.2.4.1 Alcohol use 
Most male participants acknowledged excess intake of alcohol was a cause of non-adherence to 
ART. Only one participant reported missing medication due to alcohol while the others reported 
on acquaintances having similar challenges. 
“The biggest problem which is these in most people is taking beer while taking ARVs.” [Male 36 
years] 
“Beer drinkers usually forget.” [Male 50 years] 
“The problem is that others get drunk, maybe they‟re going somewhere………..” [Male 31 
years] 
“Like me I take beer but no one has told me if it‟s wrong or right. At times I forget and take them 
after one hour.” [Male 45 years] 
“I‟ve heard of a friend of mine. The wife was complaining that he drinks too much and forgets to 
take drugs two or three days. People complain when they come to take their medication due to 
delays as they are only given little time from work.” [Male 45 years] 
4.2.4.2 Literacy/educational levels 
Participants who had attained a higher education level showed more knowledge of ART and 
could even mention the name of the medication they were taking.  
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“I take Nevipan and Truvada. In the morning I take Nevipan and in the evening I take both 
Nevipan and Truvada.” [Male 42 years] 
“I‟ve heard of stories where drug addicts are using Efavirenz.” [Male 37 years] 
Though some participants showed knowledge others spoke about needing information and 
explained that it was particularly difficult for illiterate people to gain information. 
Some of us take medication but we don‟t know why… Some us have not gone to school. We need 
to be taught what medicines we are taking. [Female 47 years] 
4.2.4.3 Disclosure and non-disclosure of HIV status 
Participants interviewed in both FGD and semi-structured interviews acknowledged that 
disclosing ones status to loved ones and family members would enhance adherence.  
“If you‟re not open to your friends and family and they don‟t know you won‟t take your 
medicine. If you hide you won‟t be free. You will wait for people to sleep and then take you 
medicine (all laugh). By this time your timing for medicine would be past. [Female 28 years] 
 “When you don‟t open up especially when you are in the wrong place you can‟t take it until you 
are in a private place so you will miss your time.” [Male 50 years] 
Participants who had disclosed shared their positive experiences of this process and the support 
they received in the taking of their ART. 
“Like for me I have disclosed. Everyone at home knows. It‟s easy because I can send anyone to 
collect the drugs for me. They even know how many I take. When I forget, they remind me by 
telling that it‟s time to take your drugs.” [Female 28 years] 
4.2.4.4 Forgetting to take medication 
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Participants (especially women) also spoke about how just working on household chores affected 
adherence.  
“As ladies what affects us a lot is homework; you are sweeping or cooking by the time you 
remember, it‟s past your time.” [Female 28 years] 
“Like me, at times there is an emergency, I forget to take my drugs in my handbag.” [Female 47 
years] 
“Sometimes because of my work I have forgotten to take my medication but not the whole day 
maybe 30 minutes but as soon as I remember, I take it. Even at church where I also a secretary 
to the pastor, when there are conferences running late I tend to forget but I am getting used to 
taking them now.” [Female 37 years] 
“Yesterday I forgot to take my drug at 20:00 hours so when I remembered I took and then early 
in the morning I took again and I felt very drunk.” [Male 31 years] 
4.2.5 Health Service Factors 
The participants reported staff attitudes, long distance, patient-health provider relationship, long 
waiting times, poor health information, counseling, trust in skills and competences of health 
workers and a standalone pharmacy as crucial to ART adherence. 
4.2.5.1 Staff attitudes 
Staff attitudes and behaviours in terms of their work was a concern. Some participants in both 
focus group discussions and individual interviews expressed frustration about the „loitering‟ of 
health care workers. Participants reported that nurses were not doing what they were supposed to 
be doing. 
“The work culture is bad. They don‟t concentrate. Sometimes the nurses just move around. A 
nurse goes to another room to chat.” [Female 37 years] 
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“They don‟t treat us well…. You arrive at 06:00 hours in the morning they come after 08:00 
hours. One time a certain nurse came and she walked out saying she has gone to the market to 
buy a pen but she never came back.” [Female 35 years] 
Nurses were also reported to be coming late. 
“Nurses come late. We come at 7 30. Today I arrived at 7 30 but the one who had the keys came 
late. 8:30 hours that‟s when they come and opened the door. You will be there waiting and 
waiting.” [Female 37 years] 
Nevertheless, not all staff attitude was perceived as negative. Some participants reported being 
listened to and receiving good care from health workers. 
“The staff and doctors are fair and welcoming. They listen to our problems. They are not in 
hurry they listen to what they say.” [Male 45 years] 
“Some staffs are good to patients, some are bad. Some ask us how are you, how are you doing 
today?” [Female 34 years] 
Receiving the drugs during the clinic visit was appreciated and an important aspect of the care 
for participants – even though they had to wait for long hours. 
“The care is there. We receive drugs every visit. I have never gone back without receiving any 
drugs. This is good though I‟ve waited for long hours.” [Male 34 years] 
4.2.5.2 Counseling 
Participants had mixed views of the adherence support, also known as counseling that they were 
given. Some felt it was adequate while others felt it was too basic and more needed to be done in 
order to improve adherence to ART. 
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“The counseling is very good. God has really taught them well. Again, the good counselors are 
the fellows who are positive because they give themselves as examples.” [Male 36 years] 
“Counseling? Counseling is very basic. Group counseling. Moderately okay. They need to do 
more.” [Male 34years] 
“I think the counseling is not good because the counselors are under paid. When you are 
motivated you do a good job. Currently they just want to clear you. Sometime we had good 
counseling.” [Female 34 years] 
“At the moment we have no counseling. They would give you basics on how to take drugs. They 
will tell you about food you eat but now no counseling.” We used to learn very well. This time we 
just queue up and wait to be attended to.” [Female 33 years] 
4.2.5.3 Lack of confidentiality 
Confidentiality within the clinic setting was an important aspect of care for the participants and 
mixed opinions and experiences were discussed. Some felt it was adequate while others felt it 
was none existent. Confidentiality revolved around health workers, patient‟s themselves and the 
environment. One male participant stated that the clinic environment was not ideal for 
confidentiality. He further felt the nurses did not observe confidentiality.  
“When you talk about confidentiality, you are talking about secrets about your issues, there is no 
confidentiality. You gather thousands and thousands (patients at clinic) and everyone can hear 
what you are discussing. No confidentiality. I feel nurses have not grasped the idea of 
confidentiality. Sometimes you over hear them discussing and pointing patients as they talk 
saying, “have you seen that one. He has done this and that.” [Male 34 years] 
“As for confidentiality, it is there among staffs and ourselves.”[Female 28 years] 
4.2.5.4 Long waiting time 
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As a result of health workers coming late to the clinic, participants reported experiencing long 
waiting times. Participants were frustrated because attending the clinic was a whole day event 
and it meant cancelling all other plans. 
“The waiting time is too much. They take too long. You come at 06:00 hours but you go home at 
13:00hours.” [Female, 33 years] 
“When you wake up and you are going to the hospital you have to suspend all other programmes 
because you will take long.” [Female 28 years] 
Those who were employed were particularly concerned about the long waiting times because 
they are only given specific time by their employers to get back to work. 
4.2.5.5 Distance from ART clinic 
The distance to be covered by patients to access ART services was reported as a barrier to 
adherence. Though most participants reported staying near the ART facility, others reported 
challenges of distance to access the ART services. 
“Here you find there are people living in the outskirts of the district like Sinde and jack 
mwanapapa. Those places are far from here. During rainy season there are streams which are 
filled with water. Someone would want come but for them to travel it is difficult. So they come 
after a week or two.” [Male 45 years] 
4.2.5.6 Poor health information system 
Most participants of the focus group discussions and interviews expressed displeasure and 
frustration at the way their laboratory results and files were being misplaced or lost by volunteers 
and registry clerks. Most respondents experienced missing laboratory results from their files and 
in some cases the whole file whenever they came back for review. Most of them stated that once 
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they were bled, they expected to find their results in their files during their review which was not 
the case for most of them.  
“We have a challenge after 3 months when you come for tests. Most of the time results get lost 
resulting into repeating tests. This is very bad.” [Female 33 years] 
 “Today they have told me my results for October are not in my file (all participants told same 
thing). They have asked me to be bled again but I told them that‟s not my job. I want my results 
in my file. Why don‟t they employ more people if there is too much work?” [Male 45 years] 
“Keeping of records there is a problem. When you come you find that the file is lost and you 
can‟t find it. They should have a system where maybe they file according to numbers. They tell 
you maybe it‟s in the data room but it‟s been three months so it can‟t be there.” [Male 37 years] 
“One doubt I have others are just volunteers there or they are untrained or trained to be there. 
Especially in the packing of files you are there 10-15 minutes they can‟t find your file. There 
needs to be a better way of doing it.”[Male 34 years] 
4.2.5.7 Patient-health provider relationship 
Participants reported that challenges with health workers attitudes towards them affected 
adherence. Some health workers were reported not to be particularly friendly. 
“Some workers are not social. They don‟t even greet. They just come and harshly say, „fendela 
uko‟ {move there} in a high voice.” [Female 28 years] 
It was noted by most participants that HIV positive staff and volunteers working in the ART 
clinic were friendlier and more responsive than those who were negative. Staff attitudes to 
patients appeared to have a direct impact on patients continuing with care. A participant during a 
focus group discussion said that he knows someone that had stopped his treatment because of his 
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experiences at the clinic. Other participants agreed and further reported that many more people 
had stopped their drugs because of health care workers attitudes. 
Another area of frustration was the difference in the way they are treated at the clinic where 
those known to staff such as their relatives were given preference even if they came into the 
clinic later than others.  
“Sometimes patients are known to staff and rather than doing their job they begin to chat with 
the known patient.” [Female 28 years] 
4.2.5.8 Skills and competences of staff 
The lack of interaction due to late arrival of clinicians also made one participant question the 
competences of the clinicians in the clinic. 
“It has to do with the competence of health personnel. I don‟t think they specialize. To them it‟s 
more like guess work. After two weeks on medication the side effects they change and change 
and change. I‟m on Truvada and Nevirapine. I was on D4T I was swelling until they changed 
me. They put me on Truvada and I am better. Efavirenz has its own problems which affects. They 
are telling you not to take alcohol and not get drunk. But the same Efavirenz makes you feel as if 
you are drunk. What does this mean (participants laugh).”[Male 34 years] 
“I‟ve read in books and other articles that other countries have HIV specialists but here we 
don‟t have. From my experience we have people who are trained for 2 weeks. People are just 
given drugs anyhow. There‟s a problem on this part …Some people would argue and argue even 
when you tell them the side effect you are experiencing…I have had this experience. 
Specialists…………..it needs to be looked at.” [Male 34 years] 
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4.8 Summary of Results 
This study found that family and partner support, patient‟s literacy levels and good patient-
provider relationship enhanced adherence while unfriendly staff hindered adherence. HIV related 
stigma and discriminations, long distance travelled to access ART, long waiting times, food 
insecurity, nature of employment, unemployment and poverty; poor health information, transport 
cost, side effects, religion, tradition, alcohol use and lack of confidentiality were barriers to ART 
adherence. 
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CHAPTER 5: DISCUSSION 
5.1 Introduction 
This study successfully established that people on ART faced many obstacles in their daily lives 
that inhibited the accessing and taking of their medications. These factors operated in different 
levels including individual, social and structural and patients had to deal or negotiate these 
barriers in order to overcome these difficulties. Despite the obstacles, most participants reported 
adhering to their ART. This chapter discusses the findings of this study in relation to other 
similar studies conducted. The chapter also discusses the study limitations. 
5.2 Economic Factors 
5.2.1 Lack of food 
Many participants reported that lack of food as a barrier to ART adherence by. The strong 
interaction between nutrition and the taking of medication was shown when participants reported 
„fearing‟ to take their ART when food was scarce because ART increased their appetites. This 
means people are already hungry and taking ART created even more hunger making the hunger 
experience worse. In addition the side effects of the drugs were enhanced in the absence of food. 
Similar findings were reported in Namibia by Thobias (2008) where patients failed to take their 
medication when hungry or when food was not available because they perceived that the 
medication was too powerful and had detrimental effects when taken on an empty stomach.  
Nutrition has been reported by Hardon et al. (2007) and Nachega et al. (2007) who suggested 
that the lack of food in resource limited settings was an important factor contributing to patients 
not taking their medication. WHO (2006) also reported food scarcity as a drawback to adherence 
in Tanzania. In the early stages of the ART programme in Zambia, the World Food Programme 
(WFP) used to provide food rations for patients on ART and tuberculosis (TB). Patients 
accessing these services at LGH were beneficiaries. The WFP has since withdrawn these services 
and currently there is no food ration provided to patients. 
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One strategy that is still being explored and implemented simultaneously in Zambia to assist 
patients is that of support groups among PLWHA within the communities. These support groups 
are given small grants and empowered with knowledge and management skills of income 
generating activities (IGAs). The funds raised through these activities are shared among support 
group members.  
5.2.2 Transport cost 
The lack of money to travel to the clinic was another barrier to ART adherence reported by some 
participants in the study as most of them were unemployed. This implies that if people had 
employment which would give them an income, they would commit part of it to transport and 
would be able to travel to the clinic for their clinical appointments and collection of drugs. Other 
studies done in similar low resource settings also reported transport costs as a barrier to ART 
adherence. One such study was that by Tuller et al. (2010) in Uganda where patients reported 
devising strategies for saving money despite the deprivations they faced or borrowed money to 
make ends meet. Others reported going into an agreement with another local HIV patient where 
when one does not have enough money, the other would travel to the clinic and in turn collect 
medication for the friend. A similar situation exists in Zambia and in particular Livingstone 
where stable patients have been assisted by health staff.In order to reduce on the burden of 
patients looking for transport money, the Ministry of Health (MoH) introduced mobile health 
services which include ART in the year 2010 which to some extent has cushioned the situation.   
5.3 Social Factors 
5.3.1 Traditional and cultural beliefs 
This study showed that traditional beliefs and practices had strong influences on people‟s ability 
to adhere to ART and this was a prominent theme in all FGDs and interviews for males and 
females. This was not surprising as the use of alternative therapy to manage health and illness in 
Africa and Zambia in particular is strongly rooted in traditional health practices and is also 
widely accepted across many cultures on the continent. Identifying the many ways it possess 
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barriers to ART is a huge challenge for successful HIV/AIDS treatment and care. The study 
showed widespread knowledge among almost all participants of alternative therapies such as 
crocodile fat, moringa tree, water from soaked groundnuts and other traditional herbs for 
HIV/AIDS management. High levels of knowledge and information on the use of alternative 
therapies in combination with ART were also noted. It was also clear that participants had to be 
strong in their belief in ART to withstand the continuous confrontation of the alternative 
therapies commonly found in their social environment. The findings on the use of alternative 
therapy in this study are similar to those reported by Wanyama et al. (2007) and Remien et al. 
(2007), the latter suggesting  that the use of alternative therapy was gaining popularity globally 
and may influence more patients to be non-adherent to ART in the future. 
Langlois-Klassen et al. (2007) and Peltzer et al. (2008) reported similar findings earlier having 
reported PLWHA using traditional herbal medicines in combination with ARVs, in studies done 
in Uganda and South Africa respectively.  Participants in this study (both male and female) 
reported how easy it was to get hold of alternative therapies on the streets. Due to this easy 
accessibility, patients had to be very resilient not to give in because it was such a common 
occurrence in their daily interactions.  
In the study done by Langlois-Klassen et al. (2007) in Uganda, it was recommended that 
HIV/AIDS programmes should be encouraged to develop patient-provider communication 
standards and best practice guidelines to ensure that patients are able to make informed decisions 
about herb and pharmaceutical drug co-therapy based on its known risks, particularly in PLWHA 
receiving antiretroviral therapy.  
The Zambian government is currently engaging traditional healers through their association to 
address these issues. 
5.3.2 Stigma and discrimination 
This study found that stigma and discrimination were prominent at family, community and work 
places but did not significantly affect adherence. People were able to labour and cope with the 
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stigma and discrimination experienced and as a result were able to adhere to their ART. The 
findings were contrary to those outlined by Hardon et al. (2007), where participants reported 
losing their jobs or being isolated by the community and families due to their HIV positive 
status. 
5.3.3 Religion 
Religion in many different forms appeared to have similar roles as traditional medicine because 
it was also shown in the study to be either used in combination with ART or as a replacement. 
These were in the form of religious beliefs, faith healing or persistent advice from church 
leaders. However the study found that religion was a very important part of participants‟ lives 
and patients themselves provided ideas on how religion could be integrated into the ART service 
in a complimentary way which would make the ART service more acceptable and which in turn 
could influence ART access and adherence. The role of religion has been reported in Nepal by 
Wasti et al. (2012) who reported the importance of religion in adherence to ART. The outlined 
findings of religion in this study are similar to those reported by Sharon et al. (2006), Wanyama 
et al. (2007), Sanjobo, Frich and Fretheim (2008) and Nam et al. (2008)   who suggest that 
religion can either facilitate or disrupt ART adherence in various ways. 
5.3.4 Family support, partner support & disclosure 
This study found that those who had disclosed their HIV status to their families and close 
acquaintances had no problems with adherence to ART because of the support rendered while 
those who had not disclosed had challenges adhering to ART. The findings of this study are 
consistent with the findings of Mills et al. (2006b) who conducted a meta-analysis from both 
developed and developing nations where non-disclosure was reported to be the most important 
barrier to adherence. Patients who had not disclosed their HIV status were more likely to suffer 
frequent treatment interruptions (Mills et al., 2006b).  This is because patients had to take their 
tablets hidden and not in the presence of others. The findings of this study are also in 
concordance with the study done by Bongololo et al. (2005) who suggest that due to lack of 
family support ART patients find it difficult to adhere to ART, because they felt unloved and 
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isolated. In this study female participants reported finding it easier to disclose to their families 
and acquaintances than their male counterparts. 
Although this study did not look at coping, mental health status (e.g. mental depression) and self-
esteem which have been reported to be related to ART use, it was clear that people with better 
support were able to adhere better to ART. This was evidenced when people spoke about 
traditional medicine, complementary and alternative medicine, religion and stigma. Fong et al. 
(2003) and Godin et al. (2005) reported the negative effects that the feeling of hopelessness had 
on ART adherence while Marc et al. (2007) suggested that acceptance of the disease and 
development of a positive attitude to ART are facilitators to ART adherence.  
5.4 Regimen Characteristics 
5.4.1 Side effects 
Side effects (from mild to severe) were commonly identified as a potential barrier to adherence 
reported by participants though none reported completely stopping their drugs. Similar findings 
were reported by Abel and Painter (2003) who noted that patients who experienced side effects 
had difficulties taking their medication. The most common side effects reported by participants 
in this study were diarrhoea, nausea and vomiting which Mocroft et al. (2001) suggests cause the 
most distress. More severe side effects such as lipodystrophy, lipoatrophy and peripheral 
neuropathy were also reported by participants in this study with no report of non-adherence to 
ART. 
5.4.2 Pill burden and complexity of treatment 
In this study, participants, especially the treatment naive reported adherence challenges due to 
the complexity of drug regimen which has to be taken at least twice daily, at the same time and is 
lifelong. The findings of this study are similar to those of Nakiyemba et al. (2002) and Williams 
and Friendland (1997) who suggest that patients adherence to a regime declines with frequency 
of dosing and poly pharmacy (e.g. prescribing four different drugs) which both add to regimen 
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complexity. ART in most cases is taken alongside opportunistic infection drugs which further 
complicate the regimen. Williams and Friedland (1997) suggest that the likelihood of a patient's 
adherence to a given regimen declines with polypharmacy (number of medicines prescribed). 
HAART consists of three agents or drugs from two different classes together with medicine for 
opportunistic infections. It is not just the quantity taken but also the size of some of the drugs 
which make them difficult to swallow. Like this study, a qualitative study done by Weiser et al. 
(2003) in Botswana found that 30% of the respondents believed that they had to swallow too 
many pills per day. Study findings from Ickovics and Meade (2002) in resource rich settings are 
in concordance with findings of this study when they report that pill burden was a major barrier 
to adherence. Lately, there have been a number of fixed dose combinations (FDCs) available for 
the management of HIV/AIDS in Zambia which will help reduce the pill burden.   
5.5 Patient Characteristics 
5.5.1 Age and Gender 
Although this study was a qualitative study age and gender did not appear to influence adherence 
to ART. The findings are similar to those reported by Marc et al. (2007) and Sarna et al. (2008) 
where age and gender were reported not to influence adherence to ART. However, the findings 
of this study do not agree with those found in the review of literature by Puskas et al. (2011) who 
noted women to be less adherent to ART than men thereby recommending further research to 
elucidate the reason for this occurrence. 
5.5.2 Alcohol and drug use 
Many accounts from participants (mostly male) showed the close relationship between alcohol 
and not taking ART.  This was mainly discussed by men with women hardly ever referring to 
this.  This could be due to the „cultural beliefs‟ where a woman is not expected to talk about or 
take alcohol. The findings of this study are in concordance with the findings in a study conducted 
in Tanzania, Botswana and Uganda  where ART users, members of the community and health 
care workers all linked alcohol abuse to non-adherence (Remien et al., 2002; WHO, 2006).  
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5.5.3 Literacy/educational levels 
Most participants in this study reported good adherence to treatment despite their level of 
education and others identified their own lack of education as a problem that prevented them 
from accessing information such as needing more time to digest information provided. A 
qualitative study done by Sanjobo, Frich and Freithman (2008) in three districts on the 
Copperbelt Province, in Zambia suggest that the level of education is not a reliable predictor of 
adherence to ART while Kip, Ehlers and Van der Wal (2009), in a study conducted in Botswana 
reported that patients with low formal education were poorer at adhering to medication due to 
their inability to read and follow instructions. Wolf et al. (2007) also reported that poor patient 
literacy was associated with more than three times greater likelihood of missed doses. In a study 
conducted in North America by Waite et al. (2008) it was found that low literacy was a 
significant risk factor for poor adherence thereby supporting the findings of this study. Graham, 
Bennett, Holmes and Gross (2007) also found that higher levels of literacy were associated with 
a more than 95% adherence rate implying that those who attain a certain level of 
education/literacy better adhere to medication. On the contrary, a study conducted by Eholie et 
al. (2007) in Cote d‟Ivoire reported a higher level of adherence amongst patients with low formal 
education. This study showed that the level of education did not influence adherence despite 
varying educational levels as outlined in the demographic profile of participants. 
5.5.4 Forgetting to take medication 
Patient forgetfulness to take medication due to work, traveling for work and home chores 
(especially females) was reported to be a barrier to adherence in this study. Similar to the 
findings of this study, WHO (2006) indicates that some study reports have indicated that 
forgetfulness was the most common reason cited by those who had problems with adherence to 
their medication. WHO (2006), Wroth and Pathman (2006), Simpson (2006) and  Heckman, 
Catz, Miller and Kalichman (2004) further report patients on ART citing various factors such as 
work, travelling for work, home tasks or attending social events as factors that led to 
forgetfulness.  
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5.6 Health Services Factors 
5.6.1 Staff attitude and patient- provider relationship 
This study found that staff attitude had the potential of affecting adherence positively or 
negatively. This was through bad work culture and late reporting at the clinic.The findings of this 
study are similar to those reported in Mozambique by Groh et al. (2011) where it was found that 
poor relationships and conflicts with health worker staff may also deter patient adherence. Male 
participants in the study by Groh et al. (2011), similar to this study focused on the lack of 
confidentiality and poor treatment by hospital staff as a major concern. WHO (2006) reports that 
negative staff attitude possibly due to low motivation and heavy workloads has been reported to 
be a barrier to ART adherence while a study conducted in Botswana by Weiser et al. (2003) 
reports  that 96% of patients were influenced to be adherent because the provider treated them 
with respect. 
5.6.2 Long waiting times, lack of confidentiality and distance from ART clinic 
Long waiting times, confidentiality and distance from the ART clinic were also identified as 
barriers to adherence in this study. Participants complained of leaving the ART clinic late even 
when they arrive early. Some reported acquaintances that left because they were impatient or 
frustrated or had to go back for work.  These findings are supported by Ickovics and Meade 
(2002) when they reported congested clinics, long waiting time and confidentiality issues as 
barriers to accessibility of health care and adherence. A study conducted in Tanzania reported 
that patients spent up to ten (10) hours at the clinic before they could be attended to and WHO 
(2006) reports that this posed as barrier to both clinic attendance and adherence. Studies 
conducted by Hardon et al. (2007) in Botswana, Tanzania and Uganda also found that long 
waiting hours discouraged patients from going to clinics.  Some participants complained of early 
closure of the clinic (13:00 hours) which denied those who came in the afternoon an opportunity 
to get their refill or be seen by the clinician. This is similar to the findings outlined by Bongololo 
et al. (2005) and a report from WHO (2006)  which suggests that limited hours of clinic 
operations adversely affected adherence as patients had to travel long distances to access ART 
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and other health services. Poor health information systems also contributed to long waiting times 
and patient participants reported concern and frustration in this study. Patients complained of 
missing or misplaced files and laboratory results thereby causing delays. This is similar to the 
findings reported by Kip et al. (2009) in a study conducted in Botswana where long waiting 
times were attributed to poor health information. 
5.7 LIMITATIONS OF THE STUDY 
This study had both strengths and limitations which need acknowledgement. This is a qualitative 
study and cannot be generalized to all patients attending Livingstone Hospital or Zambia.  The 
fact that participants were drawn from all categories of patients (treatment naïve, experienced 
and chronic) actively accessing ART at Livingstone General Hospital (LGH) can be seen as 
strength because views from all the groups would be considered thereby preventing an 
information gap or bias. Another strength was the use of two data collection methods namely 
FGD and semi-structured interviews where views were obtained from groups and individual 
patients. 
As a pharmacist, highly knowledgeable about adherence, I may have brought into the research 
my own experience and interpretations and therefore introduced bias. To minimize this, 
recording and noting exactly what participants spoke was done. Another limitation is the absence 
of data from health workers and management who are key informants. This may have led to 
information gaps or bias because only views from patients were considered.  
Errors may have been introduced during translation some points expressed in the local language 
(Tonga and Nyanja) to English. This was minimal because the researcher was quite familiar with 
both languages.  Patients could have felt obliged to participate in the study especially that the 
recruiter was a registry clerk who they could have known. Conducting the FGD and semi-
structured interviews within the hospital premises may have inhibited some patient respondents 
from expressing views freely. Lastly, the researcher being a man could have limited the depth to 
which female participants could have contributed. 
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CHAPTER 6: CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions 
The exploratory qualitative study conducted at Livingstone General Hospital in Zambia 
demonstrates that influences of adherence to ART are complex and interrelated. The study set 
out to map out factors associated with ART non-adherence at the institution. The findings 
suggest that adherence at Livingstone General Hospital is influenced by a number of factors 
ranging from economic, social, regimen, patient and health care system. The economic factors 
that were identified in this study include poverty and unemployment, lack of food and transport 
cost. The social factors identified in this study are traditional beliefs, cultural beliefs and 
religious beliefs. Regimen characteristics identified were side effects and pill burden and 
complexity of treatment. Patient characteristics such as alcohol use, stigma and discrimination, 
literacy/educational levels and forgetting to take medication were also identified to influence 
adherence. Finally, the health system factors identified were staff attitude, lack of confidentiality, 
long waiting times, distance from clinic, poor health information, patient-provider relationship, 
were identified as barriers to ART. Factors such as lack of food and unemployment require 
concerted efforts to overcome while factors such as traditional, religious, cultural beliefs and the 
identified social and health care factors can be overcome with involvement of key stakeholders 
such as health policy makers, traditional and religious leaders and health care workers. 
6.2 Recommendations 
6.2.1 Economic factors 
 Support groups should be empowered with skills for management of income generating 
activities (IGAs) so that loans/income can be made available to members.  
 Patients should be encouraged and educated on the importance of belonging to support 
groups.  
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6.2.2 Social factors 
 The health policy makers should facilitate stakeholders meetings with church leaders and 
traditional healers to educate them and sensitize them on the importance of ART in 
management of HIV/AIDS. 
 Patient education and counseling should be strengthened and the use of alternative 
treatment and cultural beliefs should be addressed at all opportunities. 
 The health care workers should encourage and support patients‟ disclosure of their HIV 
status to their close and loved ones (friends or family members) who can support the 
patient in taking their medication.  
6.2.3 Regimen and patient characteristics 
 Intensive health education and adherence counseling should be revamped at the ART 
clinic. These sessions should include drug side effects and what patients should do when 
they experience them, dangers of alcohol, stigma & discrimination and importance of 
disclosure. 
6.2.4 Health Service Factors 
 Through training, health care workers must be educated how to be non-judgmental and 
how to support patients through their treatment. 
 The hospital management through health care workers at the clinic should implement 
strategies to improve management of patient health information. 
 The hospital management should develop good practices and strategize how they can 
ensure service delivery is quickened but still maintain quality care to minimize patient 
waiting times. 
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 The existing method of tracking and tracing ART defaulters should be strengthened to 
prevent patients falling off from the program and prevent drug resistant strains of HIV. 
 Promote health education activities in the community to increase community awareness 
on HIV/AIDS and its management to enhance support for PLWHA. 
 Facilitate the provision of mobile ART services through the District Medical Office 
(DMO) especially for hard to reach areas with no ART services. 
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8. APPENDICES 
Appendix 1: Consent to be contacted by researcher 
A Zambian student at the University of the Western Cape in South Africa is conducting a study 
that will help us to better understand barriers to antiretroviral (ARV) drug adherence. We are 
hoping that the information that we will gain in this study will be used by the provincial and 
hospital management to improve services. In order to do this research he needs to interview and 
have group discussions with patients who are on antiretroviral therapy. We are not asking you to 
decide whether you want to take part in the study but we are asking that you agree to be 
contacted by the researcher. We would like for your permission for your personal details to be 
stored confidentially and given to the researcher.  If you agree he will contact you at some time 
this month (December, 2011) and he will explain to you all about the study and ask you 
permission to participate in the study. When the researcher contacts   you he will not reveal the 
reason for the call to anyone but to you.  
We are not asking you to agree to participate in the research but only to agree to be contacted by 
another person sometime in the future. You will then be free to agree to participate in the study 
or to decline. If you feel that you do not want your contact details to be passed to the researcher 
then you must feel free to say so now.  The services you receive here at the hospital remains the 
same and will not be influenced by your decision. 
Thank you  
I ___________________________________ (your name) understand the paragraphs above and 
hereby grant consent for the researcher from the University of the Western Cape to contact me. 
_________________________________ (your signature) 
My telephone numbers: __________________________ (home) 
    __________________________ (cell) 
    __________________________ (office) 
A close friend or family‟s phone number:   
   Name ________________________ 
    Number ______________________ 
Address (optional): ___________________________________________________________ 
Notes: ______________________________________________________________________ 
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Appendix 2: Participant information sheet 
                                        
                                       
UNIVERSITY OF THE WESTERN CAPE 
                    School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
            Tel: 021- 959 2809, Fax: 021- 959 2872 
                                         PARTICIPANT INFORMATION SHEET 
Dear participant 
Thank you for giving me this opportunity to talk to you about this research. What follows is an 
explanation of the purpose of the research and an explanation of what will happen and what is 
expected of you if you agree to participate. The research is being conducted for a mini-thesis 
which is a requirement for a Masters Degree in Public Health which I‟m pursuing with the 
University of the Western Cape. If there is anything that you don‟t understand or are not clear 
about, please do not hesitate to ask me. My contact details and that of my supervisors are 
recorded at the end of this memo. 
TITLE OF RESEARCH 
Antiretroviral drug adherence: A qualitative study with patients at Livingstone General Hospital. 
PURPOSE AND CONTENT OF INTERVIEW 
The research is trying to explore barriers to antiretroviral drug adherence. It is hoped that with 
your participation, a better understanding of barriers, will be gained. I plan to do interviews with 
people who are on ART. This is the reason why you have been chosen. Through interviewing 
people like yourself I hope to get information about how you take your tablets and what you find 
easy or difficult about taking the ART tablets. I will not ask many questions and it would be 
better if we have a conversation about your experiences in taking the ART drugs. 
DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT  
INTERVIEW PROCESS 
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The interview will only take a short time.  Notes will be taken and tape recording will be done. 
Recording will be done to enable all information to be captured even if it was missed when note 
taking. 
CONFIDENTIALITY 
During the interview there will be no use of names. A code will be used instead of your name. 
The discussions between you and me will be confidential. I shall keep all records of your 
participation and our discussions including a signed consent which I will need to get from you 
once you accept to participate in this research study, under lock and key at all times and will 
destroy them probably a year after the research is completed. You will not be identified in the 
written reports as they contain no names.   
VOLUNTARY PARTICIPATION AND WITHDRWAL 
Participation in this study is entirely voluntary, that is you may or may not want to participate. If 
you choose to participate, you may stop at any time. You may also choose not to answer 
particular questions in the study that you feel uncomfortable with. If there is anything that you 
would prefer not to discuss, please feel free to say so. 
BENEFITS AND COSTS 
You may not get any direct benefit from this study. However the information we will learn from 
participants in this study will contribute towards identifying barriers to antiretroviral drug 
adherence in ART services which can guide on what targeted strategies can be implored to 
address the situation. Transport allowance and refreshments will be provided. 
INFORMED CONSENT (AGREEMENT) 
Your signed consent (thumb print for those who cannot write) to participate and to be audio-
recorded in this research is requested before I can proceed to interview you. I have included the 
consent form with this information sheet so that you can review the consent form and then decide 
whether you would like to participate in this study or not. 
QUESTIONS 
Should you have further questions or wish to know more, I can be contacted as follows: 
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Kaala Moomba 
Student No. 2930764 
Cell No. +260 977 886296 /+260 965 886296 
E-mail: kmoomba@yahoo.com / kaalamoomba@gmail.com  
My supervisor‟s contact details are as follows:  
Dr. Brian Van Wyk 
University of the Western Cape 
Private Bag X17, Bellville 7535, South Africa 
Tel. +27 21 959 2872 
Fax. +27 21 959 2872 
Email: bvanwyk@uwc.ac.za 
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Appendix 3: Focus group discussion guide 
1. Tell me more about the treatments that you know to be available for treating HIV? What is 
your opinion about these? What are other people‟s opinions about these? (E.g. ARVs; herbs; 
traditional medicines; spiritual healing; prayers; and perceived benefit (s) of treatment).  
2. Tell me what it is like to take ART? (Probe about adherence, adverse effects, pill burden, 
lack of food, lifestyle issues). „ tell me what it was like to take ART”  
3. How do you think you are being treated (handled) by the health care workers (probe: privacy, 
confidentiality, respect, being listened to, time spent with patient, waiting time, integration 
with other services). What was good about the care given or attending the service (tell me 
what was not good about attending the service?) 
4. What do you think about the counseling that you receive? (Probe especially on importance of 
adherence effectiveness of counseling).  
5. What support are you given by the health workers or others to help you adhere better to your 
medications?  
6. What are the things that make adherence OR taking the drugs difficult? (Probe on timing, 
environment, etc). What makes it easy (probe) on whatever they give.  
7. In your opinion, are there things that people in the community have said about taking HIV 
drugs/ or what do people think about the taking of HIV drugs? What do you think could be 
done to help people adhere more easily to their treatment? 
Interview Closing Script 
 Thank you all for spending time with us today, for sharing your opinions and experiences 
with us. Your participation in this discussion is helping us to better understand the (program). 
 Since I‟ve asked you so many questions today, do you have any questions for me? 
 I learned a lot from our discussion today and enjoyed spending time with you (Recap) 
 Thank you very much! 
 Distribute tokens of appreciation to participants at the end. 
 
 
 
 
 
 
 
 
78 
 
 
Appendix 4: Focus group confidentiality binding form 
   
UNIVERSITY OF THE WESTERN CAPE 
                    School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
         Tel: +260 97 7 886296‟ +260 96 5 886296 
Project Title: A qualitative study of adherence to antiretroviral treatment among patients 
at Livingstone General Hospital in Hospital in Zambia. 
The study has been described to me in a language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered. I understand that my 
identity will not be disclosed and that I may withdraw from the study without giving a reason at 
any time and this will not negatively affect me in the study. I also agree not to disclose any 
information that was discussed during the group discussion. 
Participants name:………………………………………………. 
Participants signature:…………………………………………... 
Witnesses name:………………………………………………… 
Witnesses signature:……………………………………………... 
Date:………………………………………………………….. 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the researcher: 
Researcher: Kaala Moomba 
University of the Western Cape 
Private Bag X17, Bellville 7535 
Cell: +260 97 7 886296 / +260 96 5 886296 
Email: kmoomba@yahoo.com or kaalamoomba@gmail.com  
 
 
 
 
 
79 
 
Appendix 5:Semi-structured interview guide 
Name of the interviewer: Kaala Moomba    Interview Number:……….. 
DISCUSSION POINTS 
SECTION 1 
Introduction 
1. Tell me about yourself? 
2. What do you understand and think about ART? 
SECTION 2 (MAIN DISCUSSION) 
Patient/Individual factors 
3. Are there any factors that affect taking medication? (Probe: Influence of education, 
individual commitment) 
Health System/Service factors 
4. Tell me more about your experience during your ART hospital visits? (Probe on 
confidentiality/privacy, environment, waiting time). 
5. Tell me about the staff, how are they? (Probe from responses)- How is your relationship with 
them? 
6. Does this have an effect on your adherence to medication? (from 4 & 5)- (Get both –ve & 
+ve views) 
7. What support if any are you given by health workers or others to help you adhere better to 
your medication? 
Social/Economic factors 
8. Have you disclosed your status to your families and friends? If so, how easy was it for you to 
disclose your status and subsequently your taking of ARVs? What was and is the effect/their 
reaction? How does it relate to taking your ARVs? If not, why have you not disclosed? 
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9.  Probe: Work (employer, nature of work), education, substance abuse, transport (access to 
facility), commodities (availability)- get detail on how these influence adherence [both +ve & 
-ve views) 
Religion factors 
10. Has religion influenced your taking of medication?  (probe both positive and negative)- 
[Probe further on experiences of others with regards to religion and ARVs and the influence 
on adherence] 
Regimen related factors 
11. Tell me what it is like to take ART?   
(Probe about effect of daily dosing on adherence, Effects of treatment (both +ve & -ve), 
lifestyle issues, pill burden, ADRs/side effects and their effects on adherence) 
12. What makes it easy to take medication? What makes it difficult to take your medication? 
Recommendations 
What recommendations would you suggest to help you adhere better to your medication? 
INTERVIEW CLOSING SCRIPT 
o Thank you for spending time with us today, sharing your opinions and experiences with 
us. Your participation in this is helping us understand the programme better. 
o I‟ve asked you a number of questions today; do you have any questions for me? 
o I learnt a lot from our discussion today. I‟ve enjoyed the time I spent with you (Recap). 
Thank you very much 
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Appendix 6: UWC ethics clearance  
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Appendix 7: Provincial Medical Office/Livingstone General Hospital clearance 
 
 
 
 
 
83 
 
Appendix 8: Participant demographic profile 
ITEM  
What was your age at last 
birthday 
 
 
________________ 
Sex   
 Female 
 Male 
  
 
Educational level   
 None 
 Primary 
 Secondary 
 College 
 University 
  
 
Marital Status   
 Single 
 Married 
  
 
Years on ARVs 
(tick correct period) 
  
 Less than 6 months 
 Less than 1 year 
 Between 1 and 3 years 
 More than 3 years 
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Appendix 9: Informed consent form 
 
 
UNIVERSITY OF THE WESTERN CAPE 
                    School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
               Tel: 021- 959 2809, Fax: 021- 959 2872 
 INFORMED CONSENT  
 
Thank you for agreeing to allow me to interview you. I am Kaala Moomba a student at the 
School of Public Health, University of the Western Cape. As part of my Masters in Public 
Health, I am required to do a research study. I will be focusing on barriers to adherence of 
antiretroviral drugs. I am accountable to Dr. Brian Van Wyk who is contactable at Fax: +2721 
959 2872, Tel. ..................................., email: bvanwyk@uwc.ac.za or at University of the 
Western Cape, Private Bag X17, Bellville 7535, South Africa. 
THE TITLE OF THE RESEARCH IS: 
Antiretroviral drug adherence: A qualitative study with patients at Livingstone General 
Hospital. 
As mentioned in the Participant Information Sheet: Participation in this research study is entirely 
voluntary, that is you may or may not want to participate. Refusal to participate or withdrawal 
from the study will not result in penalty or any loss of benefit to which you are otherwise 
entitled. 
If you choose to participate you may stop at any time. You may also choose not to answer 
particular questions that are asked in the study. If there is anything that you prefer not to discuss 
please feel free to say so  
The discussion and information collected in this study will be kept strictly confidential. 
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If you choose to participate in this study, your signed informed consent will be required before I 
proceed with the interview with you. 
 
I have read/it has been read to me the information about this research study on the Participant‟s 
Information Sheet. I have had the opportunity to ask questions about it and any questions I have 
asked have been answered to my satisfaction. 
I voluntarily consent to be a participant and be audio-recorded in this research study and 
understand that I have the right to end the interview/recording at any time, and choose not to 
answer particular questions that are asked in the study. 
My signature indicates that I‟m willing to participate and be recorded in this research. 
Participant’s Name:_________________________________ 
Participant’s Signature/Thumb print: _________________   Date:_______________ 
Interviewer’s Signature: ______________________________Date:_______________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
